+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Therapeutic Devices Market - Global Forecast 2026-2032- Product Image
Digital Therapeutic Devices Market - Global Forecast 2026-2032- Product Image
Sale

Digital Therapeutic Devices Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336840
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Digital Therapeutic Devices Market is projected to reach USD 10.24 Billion in 2026. It is expected to continue growing at a CAGR of 19.10%, reaching USD 29.62 Billion by 2032.

Digital therapeutic devices are evidence-based software and connected medical solutions that deliver clinical interventions to prevent, manage, or treat disease. The category spans prescription digital therapeutics, software as a medical device, remote therapeutic monitoring tools, connected sensors, and app-enabled behavioral interventions for chronic disease, mental health, cardiometabolic care, respiratory conditions, neurological disorders, and rehabilitation.

Adoption is being driven by the global chronic disease burden, rising demand for mental health support, clinician shortages, aging populations, and the shift toward home-based and hybrid care. Verified indicators from the WHO, OECD, FDA, CMS, BfArM, NICE, MHRA, Health Canada, PMDA, TGA, and other public health authorities show that regulators and payers are increasingly treating clinically validated digital therapeutics as part of mainstream care delivery rather than optional wellness technology.

Transformative Shifts in the Digital Therapeutics Landscape

The digital therapeutic devices landscape is shifting from pilot programs to regulated, reimbursable, outcomes-oriented deployment. FDA-cleared software, Germany’s DiGA pathway, France’s early-access PECAN framework, the UK’s NICE evidence standards, and software as a medical device guidance across major regulators demonstrate a stronger policy foundation for clinically validated digital health interventions.

Commercial success now depends on proof of clinical benefit, patient engagement, interoperability, cybersecurity, accessibility, and workflow integration. Providers are prioritizing solutions that reduce avoidable visits, support remote care, and generate measurable outcomes, while payers increasingly expect real-world evidence, health economics data, durable adherence, and transparent performance reporting across diverse patient populations.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the value of digital therapeutic devices by enabling adaptive interventions, risk stratification, adherence support, clinical decision support, symptom pattern recognition, and personalized behavior-change pathways. AI can help software respond to patient-reported outcomes, biomarker trends, and connected-device data in near real time, supporting more individualized care between clinical encounters.

The cumulative impact is significant but dependent on governance. Industry leaders must align AI-enabled digital therapeutics with FDA, Health Canada, MHRA, European, and international Good Machine Learning Practice principles, while addressing algorithmic bias, explainability, cybersecurity, data provenance, human oversight, model drift, and ongoing post-market monitoring.

Key Regional Insights

North America remains a leading region for digital therapeutic devices because of FDA software as a medical device guidance, CMS remote therapeutic monitoring codes, strong employer health programs, established clinical research networks, and growing provider interest in remote care. Europe is advancing through the EU Medical Device Regulation, Germany’s DiGA reimbursement model, France’s PECAN framework, and NICE evidence standards in the United Kingdom, creating a structured environment for clinically validated digital therapeutics and digital health technology assessment.

Asia-Pacific is scaling through Japan’s PMDA review environment, South Korea’s digital health pilots, China’s large connected-health ecosystem, India’s public digital health infrastructure, and Australia’s TGA framework. Latin America is progressing through telehealth expansion in Brazil and Mexico, with demand shaped by access gaps and chronic disease management needs. The Middle East is supported by national digital health strategies, especially in GCC markets investing in connected hospitals and health system modernization. Africa shows long-term potential through mobile-first care models and public health digitization, although reimbursement, broadband access, clinical validation infrastructure, and procurement pathways remain uneven across countries.

Key Group Insights

The European Union is shaping digital therapeutic device adoption through harmonized medical device rules, data protection standards, electronic health initiatives, and cross-border digital health priorities. G7 markets continue to influence evidence expectations, reimbursement models, cybersecurity practices, AI governance, and post-market surveillance norms for regulated digital health solutions.

BRICS countries provide scale, diverse disease burdens, expanding smartphone access, and growing digital public infrastructure, making localization, affordability, language adaptation, and public-private care integration essential. ASEAN markets are mobile-first and benefit from expanding telehealth acceptance, urban hospital digitization, and government digital health strategies. GCC countries are investing in national health transformation programs, connected hospitals, and preventive care initiatives. NATO markets place additional emphasis on cyber resilience, secure health data exchange, trusted cloud infrastructure, and continuity of care across defense and civilian health systems.

Key Country Insights

The United States leads through FDA authorization pathways, CMS reimbursement mechanisms, employer adoption, academic clinical research, and strong digital health innovation. Canada is advancing through Health Canada oversight, provincial procurement, and virtual care integration, while Mexico and Brazil show demand linked to telehealth access, private health networks, chronic disease management, and uneven specialist availability across regions.

In Europe, the United Kingdom is guided by MHRA and NICE evidence standards, Germany by DiGA and BfArM processes, France by HAS and PECAN, and Italy and Spain by regional health system adoption and digital care modernization. Russia is emphasizing domestic digital health capacity and locally controlled health technology infrastructure. In Asia-Pacific, China, India, Japan, Australia, and South Korea are each scaling through different combinations of regulatory modernization, public digital infrastructure, connected-device adoption, telemedicine acceptance, clinical validation requirements, and increasing focus on cybersecurity and patient data protection.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated use cases where digital therapeutic devices can reduce care gaps, improve outcomes, or extend access to care. Early engagement with regulators, payers, clinicians, health technology assessment bodies, and patient groups is essential to align product claims, study design, evidence endpoints, data security, accessibility, and reimbursement strategy.

Organizations should build interoperable platforms using recognized standards such as HL7 FHIR, invest in real-world evidence, and implement AI governance from development through post-market surveillance. Commercial models should emphasize measurable outcomes, patient retention, clinician usability, health equity, localization, cybersecurity, and integration with existing electronic health record workflows.

Research Methodology

This executive summary is based on structured secondary research using verified public sources, including regulatory guidance, reimbursement policies, clinical trial registries, public health datasets, payer documentation, health technology assessment materials, and peer-reviewed literature. Key reference authorities include the FDA, CMS, WHO, OECD, ITU, EMA, BfArM, NICE, MHRA, Health Canada, PMDA, TGA, and national digital health agencies.

Insights were triangulated across regulatory, clinical, commercial, technology, and regional indicators to avoid reliance on unsupported claims. Emphasis was placed on validated market drivers, policy developments, adoption barriers, interoperability requirements, evidence standards, AI governance considerations, and regional access factors affecting digital therapeutic devices.

Conclusion

Digital therapeutic devices are moving into a more mature phase defined by clinical evidence, regulatory discipline, reimbursement readiness, interoperability, cybersecurity, and AI-enabled personalization. The strongest opportunities are emerging where software-based interventions solve measurable care gaps in chronic disease, behavioral health, rehabilitation, medication adherence, and remote monitoring.

Organizations that combine rigorous evidence generation, secure data architecture, clinician-friendly workflows, accessible patient experiences, and payer-aligned value propositions will be best positioned to lead. As global health systems demand scalable, equitable, and cost-effective care, digital therapeutics are becoming a critical layer of modern medical technology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Digital Therapeutic Devices Market, by Therapeutic Area
7.1. Introduction
7.2. Cardiovascular
7.2.1. Heart Failure
7.2.2. Hypertension
7.3. Diabetes Management
7.3.1. Type 1 Diabetes
7.3.2. Type 2 Diabetes
7.4. Mental Health
7.4.1. Anxiety
7.4.2. Depression
7.4.3. Stress Management
7.5. Musculoskeletal
7.5.1. Chronic Pain
7.5.2. Physical Rehabilitation
7.6. Respiratory
7.6.1. Asthma
7.6.2. Copd
8. Digital Therapeutic Devices Market, by Delivery Mode
8.1. Introduction
8.2. Mobile
8.3. VR AR
8.4. Wearable
8.5. Web
9. Digital Therapeutic Devices Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online Platforms
10. Digital Therapeutic Devices Market, by End User
10.1. Introduction
10.2. Home Settings
10.3. Hospitals And Clinics
10.4. Research Institutes
11. Digital Therapeutic Devices Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Digital Therapeutic Devices Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Digital Therapeutic Devices Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 2Morrow, Inc.
15.2. Akili Interactive Labs, Inc.
15.3. Allurion Technologies, Inc.
15.4. AppliedVR, Inc.
15.5. Better Therapeutics, Inc.
15.6. Big Health Ltd.
15.7. Biofourmis, Inc.
15.8. Blue Note Therapeutics, Inc.
15.9. Canary Health, Inc.
15.10. Click Therapeutics, Inc.
15.11. CureApp, Inc.
15.12. DarioHealth Corp.
15.13. GAIA AG
15.14. Kaia Health Software GmbH
15.15. Lark Health, Inc.
15.16. MedRhythms, Inc.
15.17. Medtronic plc
15.18. Meru Health Inc.
15.19. MindMaze SA
15.20. Noom, Inc.
15.21. Omada Health, Inc.
15.22. Otsuka Holdings Co., Ltd.
15.23. Pear Therapeutics, Inc.
15.24. Propeller Health, Inc.
15.25. Teladoc Health, Inc.
15.26. Vida Health, Inc.
15.27. WellDoc, Inc.
List of Figures
FIGURE 1. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MENTAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MENTAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MENTAL HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ANXIETY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ANXIETY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ANXIETY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL STRESS MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL STRESS MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL STRESS MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MUSCULOSKELETAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MUSCULOSKELETAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MUSCULOSKELETAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PHYSICAL REHABILITATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PHYSICAL REHABILITATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PHYSICAL REHABILITATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ASTHMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ASTHMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ASTHMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL COPD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL COPD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL COPD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MOBILE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MOBILE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MOBILE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL VR AR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL VR AR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL VR AR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL WEARABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL WEARABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL WEARABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL WEB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL WEB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL WEB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ONLINE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ONLINE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ONLINE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOME SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOME SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOME SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 115. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 116. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 117. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 118. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 119. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 120. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 121. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 122. EUROPE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 135. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 136. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 137. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 138. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 139. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 140. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 141. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 142. AFRICA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 146. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 147. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 148. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 149. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 150. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 151. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 152. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 153. ASEAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 156. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 157. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 158. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 159. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 160. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 161. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 162. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 163. GCC DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 176. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 177. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 178. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 179. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 180. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 181. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 182. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 183. BRICS DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 186. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 187. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 188. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 189. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 190. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 191. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 192. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 193. G7 DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 194. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 196. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 197. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 198. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 199. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 200. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 201. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 202. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 203. NATO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 217. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 218. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 219. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 220. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 221. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 222. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 223. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 224. CANADA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 227. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 228. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 229. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 230. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 231. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 232. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 233. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 234. MEXICO DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 236. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 237. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 238. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 239. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 240. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 241. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 242. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 243. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 257. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 258. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 259. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 260. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 261. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 262. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 263. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 264. GERMANY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 267. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 268. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 269. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 270. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 271. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 272. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 273. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 274. FRANCE DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 277. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 278. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 280. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 287. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 288. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 289. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 290. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 291. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 292. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 293. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 294. ITALY DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 297. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 298. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 299. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 300. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 301. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 302. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 303. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 304. SPAIN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 307. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 308. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 309. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 310. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 311. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 312. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 313. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 314. CHINA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 317. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 318. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 319. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 320. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 321. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 322. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 323. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 324. INDIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 327. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 328. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 329. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 330. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MUSCULOSKELETAL, 2017-2032 (USD MILLION)
TABLE 331. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 332. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 333. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 334. JAPAN DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. AUSTRALIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. AUSTRALIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 337. AUSTRALIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 338. AUSTRALIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 339. AUSTRALIA DIGITAL THERAPEUTIC DEVICES MARKET SIZE, BY MENTAL HEALTH, 2017-2032 (USD MILLION)
TABLE 340. AUSTRA

Companies Mentioned

  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc.
  • Allurion Technologies, Inc.
  • AppliedVR, Inc.
  • Better Therapeutics, Inc.
  • Big Health Ltd.
  • Biofourmis, Inc.
  • Blue Note Therapeutics, Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • CureApp, Inc.
  • DarioHealth Corp.
  • GAIA AG
  • Kaia Health Software GmbH
  • Lark Health, Inc.
  • MedRhythms, Inc.
  • Medtronic plc
  • Meru Health Inc.
  • MindMaze SA
  • Noom, Inc.
  • Omada Health, Inc.
  • Otsuka Holdings Co., Ltd.
  • Pear Therapeutics, Inc.
  • Propeller Health, Inc.
  • Teladoc Health, Inc.
  • Vida Health, Inc.
  • WellDoc, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.24 Billion
Forecasted Market Value ( USD ) by 2032 $ 29.62 Billion
Compound Annual Growth Rate19.1%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Digital Therapeutics Market - Global Forecast 2026-2032 - Product Image

Digital Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032) - Product Image

Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032)

  • Report
  • 105 Pages
  • Global
From
Digital Therapeutics Market Report by Application, End Use, and Region 2026-2034 - Product Image

Digital Therapeutics Market Report by Application, End Use, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Digital Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Digital Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 160 Pages
  • Global
From
Digital Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Digital Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.